Krieg Arthur M 4
4 · Checkmate Pharmaceuticals, Inc. · Filed Mar 31, 2021
Insider Transaction Report
Form 4
Krieg Arthur M
Chief Scientific Officer
Transactions
- Purchase
Common Stock
2021-03-29$10.94/sh+17,468$191,100→ 764,179 total - Purchase
Common Stock
2021-03-29$11.40/sh+15,752$179,573→ 779,931 total
Holdings
- 68,457(indirect: See footnote)
Common Stock
- 68,457(indirect: See footnote)
Common Stock
- 68,457(indirect: See footnote)
Common Stock
Footnotes (3)
- [F1]The price reported in column 4 is a weighted average price. Pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person, these shares were purchased in multiple transactions, at prices ranging from $10.65 to $11.21 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
- [F2]The price reported in column 4 is a weighted average price. Pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person, these shares were purchased in multiple transactions, at prices ranging from $11.22 to $12.19 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
- [F3]The shares are held by an irrevocable trust for the Reporting Person's child. The Reporting Person serves as trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.